Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AURO-ESLICARBAZEPINE DIN 02527448

Status: Marketed
Holder: AURO PHARMA INC
Molecule: ESLICARBAZEPINE ACETATE
Available to quote

Health Canada record

Active ingredient(s)ESLICARBAZEPINE ACETATE 400 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN03AF04 ESLICARBAZEPINE
Original market date08-May-2025
Current status date08-May-2025
SourceHealth Canada DPD

Establishment licence of the holder

Auro Pharma Inc — licence 101305, currently licensed, last inspection rating C (2023-09-27).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ESLICARBAZEPINE ACETATE

DINProductCompanyFormStrengthStatus
02537974APO-ESLICARBAZEPINEAPOTEX INCTabletESLICARBAZEPINE ACETATE 800 MGMarketed
02537931APO-ESLICARBAZEPINEAPOTEX INCTabletESLICARBAZEPINE ACETATE 200 MGMarketed
02537966APO-ESLICARBAZEPINEAPOTEX INCTabletESLICARBAZEPINE ACETATE 600 MGMarketed
02537958APO-ESLICARBAZEPINEAPOTEX INCTabletESLICARBAZEPINE ACETATE 400 MGMarketed
02527456AURO-ESLICARBAZEPINEAURO PHARMA INCTabletESLICARBAZEPINE ACETATE 600 MGMarketed
02527421AURO-ESLICARBAZEPINEAURO PHARMA INCTabletESLICARBAZEPINE ACETATE 200 MGMarketed
02527464AURO-ESLICARBAZEPINEAURO PHARMA INCTabletESLICARBAZEPINE ACETATE 800 MGMarketed
02426862APTIOMSUMITOMO PHARMA CANADA, INC.TabletESLICARBAZEPINE ACETATE 200 MGCancelled Post Market
02426897APTIOMSUMITOMO PHARMA CANADA, INC.TabletESLICARBAZEPINE ACETATE 800 MGCancelled Post Market
02426889APTIOMSUMITOMO PHARMA CANADA, INC.TabletESLICARBAZEPINE ACETATE 600 MGCancelled Post Market
02426870APTIOMSUMITOMO PHARMA CANADA, INC.TabletESLICARBAZEPINE ACETATE 400 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
353122025-05-07Abbreviated New Drug Submission (ANDS)

International API supply for ESLICARBAZEPINE ACETATE

17 active FDA Drug Master Files.

Request a quote for AURO-ESLICARBAZEPINE

How to read a Canadian DIN record